Patent · US Active

Oligonucleotides for modulating gene expression and uses thereof

US10023867B2 · kind B2 · utility

0Cited by
0References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 21, 2013
Grant dateJul 17, 2018
Priority date
Expiry dateFeb 1, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/31
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoral or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.